These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35685462)

  • 41. Alkaptonuria in Russia.
    Soltysova A; Kuzin A; Samarkina E; Zatkova A
    Eur J Hum Genet; 2022 Feb; 30(2):237-242. PubMed ID: 34504318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early-onset ocular ochronosis in a girl with alkaptonuria (AKU) and a novel mutation in homogentisate 1,2-dioxygenase (HGD).
    Gucev ZS; Slaveska N; Laban N; Danilovski D; Tasic V; Pop-Jordanova N; Zatkova A
    Prilozi; 2011; 32(1):305-11. PubMed ID: 21822197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-Function Relationship of Homogentisate 1,2-dioxygenase: Understanding the Genotype-Phenotype Correlations in the Rare Genetic Disease Alkaptonuria.
    Bernini A; Spiga O; Santucci A
    Curr Protein Pept Sci; 2023; 24(5):380-392. PubMed ID: 36880186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre.
    Ranganath LR; Khedr M; Milan AM; Davison AS; Hughes AT; Usher JL; Taylor S; Loftus N; Daroszewska A; West E; Jones A; Briggs M; Fisher M; McCormick M; Judd S; Vinjamuri S; Griffin R; Psarelli EE; Cox TF; Sireau N; Dillon JP; Devine JM; Hughes G; Harrold J; Barton GJ; Jarvis JC; Gallagher JA
    Mol Genet Metab; 2018 Sep; 125(1-2):127-134. PubMed ID: 30055994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Three-generational alkaptonuria in a non-consanguineous family.
    Oexle K; Engel K; Tinschert S; Haas D; Lee-Kirsch MA
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S425-30. PubMed ID: 19096913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation spectrum of homogentisic acid oxidase (HGD) in alkaptonuria.
    Vilboux T; Kayser M; Introne W; Suwannarat P; Bernardini I; Fischer R; O'Brien K; Kleta R; Huizing M; Gahl WA
    Hum Mutat; 2009 Dec; 30(12):1611-9. PubMed ID: 19862842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic Effects of Increasing Doses of Nitisinone in the Treatment of Alkaptonuria.
    Gertsman I; Barshop BA; Panyard-Davis J; Gangoiti JA; Nyhan WL
    JIMD Rep; 2015; 24():13-20. PubMed ID: 25665838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of low dose nitisinone in the management of alkaptonuria.
    Sloboda N; Wiedemann A; Merten M; Alqahtani A; Jeannesson E; Blum A; Henn-Ménétré S; Guéant JL; Renard E; Feillet F
    Mol Genet Metab; 2019 Jul; 127(3):184-190. PubMed ID: 31235217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of the mutation in the alkaptonuria mouse model. Mutations in brief no. 216. Online.
    Manning K; Fernández-Cañón JM; Montagutelli X; Grompe M
    Hum Mutat; 1999; 13(2):171. PubMed ID: 10094559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of Melanin-like Pigment Synthesized from Homogentisic Acid, with or without Tyrosine, and Its Implications in Alkaptonuria.
    Taylor AM; Vercruysse KP
    JIMD Rep; 2017; 35():79-85. PubMed ID: 27943071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toward a generalized computational workflow for exploiting transient pockets as new targets for small molecule stabilizers: Application to the homogentisate 1,2-dioxygenase mutants at the base of rare disease Alkaptonuria.
    Bernini A; Galderisi S; Spiga O; Bernardini G; Niccolai N; Manetti F; Santucci A
    Comput Biol Chem; 2017 Oct; 70():133-141. PubMed ID: 28869836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy.
    Nemethova M; Radvanszky J; Kadasi L; Ascher DB; Pires DE; Blundell TL; Porfirio B; Mannoni A; Santucci A; Milucci L; Sestini S; Biolcati G; Sorge F; Aurizi C; Aquaron R; Alsbou M; Lourenço CM; Ramadevi K; Ranganath LR; Gallagher JA; van Kan C; Hall AK; Olsson B; Sireau N; Ayoob H; Timmis OG; Sang KH; Genovese F; Imrich R; Rovensky J; Srinivasaraghavan R; Bharadwaj SK; Spiegel R; Zatkova A
    Eur J Hum Genet; 2016 Jan; 24(1):66-72. PubMed ID: 25804398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria.
    Bernardini G; Leone G; Millucci L; Consumi M; Braconi D; Spiga O; Galderisi S; Marzocchi B; Viti C; Giorgetti G; Lupetti P; Magnani A; Santucci A
    J Cell Physiol; 2019 May; 234(5):6696-6708. PubMed ID: 30341892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of HGD Gene Mutations in Patients with Alkaptonuria from the United Kingdom: Identification of Novel Mutations.
    Usher JL; Ascher DB; Pires DE; Milan AM; Blundell TL; Ranganath LR
    JIMD Rep; 2015; 24():3-11. PubMed ID: 25681086
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model.
    Tinti L; Spreafico A; Braconi D; Millucci L; Bernardini G; Chellini F; Cavallo G; Selvi E; Galeazzi M; Marcolongo R; Gallagher JA; Santucci A
    J Cell Physiol; 2010 Oct; 225(1):84-91. PubMed ID: 20648626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria.
    Davison AS; Norman BP; Sutherland H; Milan AM; Gallagher JA; Jarvis JC; Ranganath LR
    Metabolites; 2022 May; 12(6):. PubMed ID: 35736410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of nitisinone in patients with alkaptonuria.
    Suwannarat P; O'Brien K; Perry MB; Sebring N; Bernardini I; Kaiser-Kupfer MI; Rubin BI; Tsilou E; Gerber LH; Gahl WA
    Metabolism; 2005 Jun; 54(6):719-28. PubMed ID: 15931605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum markers in alkaptonuria: simultaneous analysis of homogentisic acid, tyrosine and nitisinone by liquid chromatography tandem mass spectrometry.
    Hughes AT; Milan AM; Davison AS; Christensen P; Ross G; Gallagher JA; Dutton JJ; Ranganath LR
    Ann Clin Biochem; 2015 Sep; 52(Pt 5):597-605. PubMed ID: 25628464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute fatal metabolic complications in alkaptonuria.
    Davison AS; Milan AM; Gallagher JA; Ranganath LR
    J Inherit Metab Dis; 2016 Mar; 39(2):203-10. PubMed ID: 26596578
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.